Hubbry Logo
Kay Redfield JamisonKay Redfield JamisonMain
Open search
Kay Redfield Jamison
Community hub
Kay Redfield Jamison
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Kay Redfield Jamison
Kay Redfield Jamison
Kay Redfield Jamison
View on Wikipedia
from Wikipedia

Kay Redfield Jamison (born June 22, 1946) is an American clinical psychologist and writer. Her work has centered on bipolar disorder, which she has had since her early adulthood. She holds the post of the Dalio Professor in Mood Disorders and Psychiatry at Johns Hopkins University School of Medicine and is an Honorary Professor of English at the University of St Andrews.

Key Information

Education and career

[edit]

Jamison began her study of clinical psychology at University of California, Los Angeles in the late 1960s, receiving both B.A. and M.A. degrees in 1971. She continued on at UCLA, receiving a C.Phil. in 1973 and a PhD in 1975, and became a faculty member at the university. She went on to found and direct the school's Affective Disorders Clinic, a large teaching and research facility for outpatient treatment. She also studied zoology and neurophysiology as an undergraduate at the University of St. Andrews in Scotland.

After several years as a tenured professor at UCLA, Jamison was offered a position as Assistant Professor and then Professor of Psychiatry at the Johns Hopkins University School of Medicine. Jamison has given visiting lectures at a number of different institutions while maintaining her professorship at Hopkins. She was distinguished lecturer at Harvard University in 2002 and the Litchfield lecturer at the University of Oxford in 2003. She was Honorary President and board member of the Canadian Psychological Association from 2009 to 2010. In 2010, she was a panelist in the series of discussions on the latest research into the brain, hosted by Charlie Rose with series scientist Eric Kandel on PBS.[1]

Awards and recognition

[edit]
Jamison at a lectern looking to the side
Jamison at a book fair in 2017

Jamison has won numerous awards and published over 100 academic articles. She has been named one of the "Best Doctors in the United States" and was chosen by Time as a "Hero of Medicine."[2] She was also chosen as one of the five individuals for the public television series Great Minds of Medicine.[3][4] Jamison is the recipient of the National Mental Health Association's William Styron Award (1995), the American Foundation for Suicide Prevention Research Award (1996), the Community Mental Health Leadership Award (1999), and was a 2001 MacArthur Fellowship recipient. In 2010, Jamison was conferred with an Honorary Degree of Doctor of Letters from the University of St Andrews in recognition of all her life's work.[5][6] In May 2011, The General Theological Seminary of the Episcopal Church, New York, made her a Doctor of Divinity honoris causa at its annual Commencement.[7] In 2017 Jamison was elected a Corresponding Fellow of the Royal Society of Edinburgh (CorrFRSE).[8]

Academic contributions

[edit]

Her latest book, Robert Lowell: Setting the River on Fire, was a Pulitzer Prize Finalist for Biography in 2018.

Her book Manic-Depressive Illness, first published in 1990 and co-authored with psychiatrist Frederick K. Goodwin is considered a classic textbook on bipolar disorder. The Acknowledgements section states that Goodwin "received unrestricted educational grants to support the production of this book from Abbott, AstraZeneca, Bristol Meyers Squibb, Forest, GlaxoSmithKline, Janssen, Eli Lilly, Pfizer, and Sanofi", but that although Jamison has "received occasional lecture honoraria from AstraZeneca, GlaxoSmithKline, and Eli Lilly" she "has received no research support from any pharmaceutical or biotechnology company" and donates her royalties to a non-profit foundation.

Her seminal works among laypeople are her memoir An Unquiet Mind, which details her experience with severe mania and depression, and Night Falls Fast: Understanding Suicide, providing historical, religious, and cultural responses to suicide, as well as the relationship between mental illness and suicide. In Night Falls Fast, Jamison dedicates a chapter to American public policy and public opinion as it relates to suicide. Her second memoir, Nothing Was the Same, examines her relationship with her second husband, the psychiatrist Richard Jed Wyatt, who was Chief of the Neuropsychiatry Branch of the National Institute of Mental Health until his death in 2002.

In her study Exuberance: The Passion for Life, she cites research that suggests that 15 percent of people who could be diagnosed as bipolar may never actually become depressed; in effect, they are permanently "high" on life. She mentions President Theodore Roosevelt as an example.

Touched with Fire: Manic-Depressive Illness and the Artistic Temperament is Jamison's exploration of how bipolar disorder can run in artistic or high-achieving families. As an example, she cites Lord Byron and his relatives.

Jamison wrote An Unquiet Mind: A Memoir of Moods and Madness in part to help clinicians see what patients find helpful in therapy. J. Wesley Boyd, an assistant professor at the Department of Psychiatry at Tufts University's School of Medicine, wrote, "Jamison's description [of the debt she owed her psychiatrist] illustrates the importance of merely being present for our patients and not trying to soothe them with platitudes or promises of a better future."[9]

Personal life

[edit]

Jamison has said she is an "exuberant" person who longs for peace and tranquility but in the end prefers "tumultuousness coupled to iron discipline" to a "stunningly boring life."[10] In An Unquiet Mind, she concluded:

I long ago abandoned the notion of a life without storms, or a world without dry and killing seasons. Life is too complicated, too constantly changing, to be anything but what it is. And I am, by nature, too mercurial to be anything but deeply wary of the grave unnaturalness involved in any attempt to exert too much control over essentially uncontrollable forces. There will always be propelling, disturbing elements, and they will be there until, as Lowell put it, the watch is taken from the wrist. It is, at the end of the day, the individual moments of restlessness, of bleakness, of strong persuasions and maddened enthusiasms, that inform one's life, change the nature and direction of one's work, and give final meaning and color to one's loves and friendships.[11]

Jamison was born to Dr. Marshall Verdine Jamison (1916–2012), an officer in the U.S. Air Force, and Mary Dell Temple Jamison (1916–2007).[12][13] Jamison's father, and many others in his family, had bipolar disorder.[13]

As a result of Jamison's military background, she grew up in many different places, including Florida, Puerto Rico, California, Tokyo, and Washington, D.C. She has two older siblings, a brother and a sister, who are three years and half a year older, respectively.[13] Her niece is writer Leslie Jamison.[14] Jamison's interest in science and medicine began at a young age and was fostered by her parents. She worked as a candy striper at the hospital on Andrews Air Force Base.[13]

Jamison moved to California during adolescence, and soon thereafter began to struggle with bipolar disorder. She continued to struggle in college at UCLA. At first she wanted to become a doctor, but because of increasing occurring manic episodes, she decided she could not maintain the rigorous discipline needed for medical school. Jamison then found her calling in psychology. Here she flourished and was extremely interested in mood disorders. Despite her studies, Jamison did not realize that she was bipolar until three months into her first job as a professor in UCLA's Department of Psychology. After her diagnosis, she was put on lithium, a drug that has commonly been used to regulate and moderate moods. At times, she would refuse the medication because it impaired her motor skills, but after a greater depression she decided to continue to take it. Jamison once attempted suicide by overdosing on lithium during a severe depressive episode.

Jamison is an Episcopalian,[15] and she was married to her first husband, Alain André Moreau, an artist, during her graduate school years.[13] She later married Dr. Richard Wyatt in 1994;[16] and they remained married until his death in 2002.[17] Wyatt was a psychiatrist who studied schizophrenia at the National Institutes of Health. Their romance is detailed in her memoir Nothing Was the Same.

In 2010, Jamison married Thomas Traill, a cardiology professor at Johns Hopkins.[18]

Bibliography

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Kay Redfield Jamison

View on Grokipedia
from Grokipedia
Kay Redfield Jamison is an American clinical and specializing in mood disorders, particularly , with contributions informed by both empirical research and her personal experience with manic-depressive illness. She holds the Dalio Professorship in Mood Disorders and serves as Professor of at the School of Medicine, where she co-directs the Mood Disorders Center. Jamison's memoir : A Memoir of Moods and Madness (1995) offers a firsthand account of her struggles with , including manic episodes and a , helping to reduce stigma around the condition. Alongside Frederick K. Goodwin, she co-authored Manic-Depressive Illness: and Recurrent Depression (1990), a foundational textbook synthesizing clinical and scientific evidence on the , treatment, and neurobiology of that remains influential in . Her research emphasizes the efficacy of in managing and explores links between mood disorders, creativity, and , as detailed in works like Touched with Fire (1993) and Night Falls Fast (1999). Jamison received a MacArthur Fellowship in 2001 for advancing treatment through her interdisciplinary approach combining , , and .

Early Life and Education

Family Background and Childhood

Kay Redfield Jamison was born on June 22, 1946, in , as the youngest of three children to Marshall Verdine Jamison, a U.S. Air Force officer specializing in , and Mary Dell Temple Jamison. Her father, who held a and served in various and operational roles within the , emphasized scientific curiosity and enthusiasm, often engaging the family in intellectual pursuits despite the demands of his career. Her mother managed the household amid frequent relocations, fostering a structured environment in line with military family norms. The family's peripatetic lifestyle, dictated by her father's assignments, involved living in multiple locations including , , , , and Washington, D.C., by the time Jamison reached . This mobility exposed her to diverse environments but also instilled resilience and adaptability, characteristics she later attributed to her upbringing in a disciplined context. Her older brother, Dean Jamison, pursued an academic career in and , while her sister exhibited a more volatile temperament, contributing to complex dynamics marked by both support and tension. Jamison recalled her childhood as generally happy and active, with participation in athletics such as and a budding interest in science inspired by her father's passion for and . She demonstrated early academic aptitude and creativity, though the family's emphasis on —typical of households—discouraged overt emotional expression. These formative experiences, amid a backdrop of paternal to mood instability later noted in family members, shaped her foundational worldview without overt disruption during youth.

Academic Training and Influences

Jamison pursued her undergraduate and graduate education at the (UCLA), where she began studying in the late 1960s. She earned a B.A. and M.A. in 1971, a C.Phil. in 1973, and a Ph.D. in in 1975. During her doctoral program, she completed a residency in at UCLA's Neuropsychiatric Institute in 1974, focusing on practical training in assessment and intervention. Her training was supported by competitive research fellowships that emphasized empirical investigation, including the Research Fellowship, Predoctoral Research Fellowship, University of California Cook Scholarship, and Scholarship; she was also named UCLA Graduate Woman of the Year. These awards underscored an early orientation toward scientifically rigorous approaches in , blending with neurobiological . Jamison further broadened her perspective through studies in and at the in , though she did not earn a degree there. This interdisciplinary exposure likely informed her later integration of biological and psychological models in research.

Professional Career

Academic Positions and Roles

Jamison began her academic career at the (UCLA), where she earned her B.A. and M.A. degrees in in 1971, followed by her C.Phil. in 1973 and Ph.D. in 1975. She joined the UCLA faculty as an assistant professor of and advanced to in 1981. During this period, she founded and directed the UCLA Affective Disorders Clinic, focusing on mood disorders research and treatment. Jamison achieved tenure at UCLA after several years, a milestone she pursued amid personal health challenges, securing her position as a tenured professor. In 1987, Jamison transitioned to Johns Hopkins University School of Medicine, accepting a tenured appointment as Professor of Psychiatry in the Department of Psychiatry and Behavioral Sciences. She holds the Dalio Professorship in , a named chair emphasizing her expertise in affective illnesses. Jamison also serves as co-director of the Johns Hopkins Mood Disorders Center, overseeing clinical, research, and educational initiatives in and related conditions. These roles have enabled her to integrate empirical research with clinical practice, contributing to advancements in diagnostics and management.

Clinical and Research Engagements

Jamison holds the position of Dalio Professor in Mood Disorders and serves as Professor of and Behavioral Sciences at the School of Medicine, where she co-directs the Mood Disorders Center. In these roles, she contributes to clinical care for patients with severe mood disorders, including , emphasizing assessment, , and evidence-based pharmacological management informed by longitudinal patient outcomes. Her clinical engagements integrate empirical data from patient histories to refine treatment protocols, such as addressing medication non-compliance, which she has identified as a persistent challenge due to the cognitive distortions during manic phases. In research, Jamison has focused on the phenomenology of , suicide risk, and the intersection of mood instability with , drawing from large-scale analyses of clinical cohorts and historical case studies. A key collaboration was with Frederick K. Goodwin, resulting in the 1990 publication (second edition 2007) of Manic-Depressive Illness, a comprehensive synthesis of over 2,000 studies on 's etiology, course, and treatment, which incorporates data on genetic vulnerabilities, neurobiological markers, and long-term outcomes from treated versus untreated cases. Her empirical investigations include a 1989 study examining 47 British writers and artists, which documented elevated rates of manic-depressive illness (36.6% lifetime of bipolar spectrum disorders versus 7.2% in controls), linking cyclothymic temperaments to creative productivity through and family history verification. Additional research engagements encompass studies on and ethical dimensions of bipolar treatment, such as a pilot investigation into patient and spouse attitudes toward research participation and in trials. Jamison advocates for patient involvement in shaping clinical trials and care protocols, arguing from observational data that lived experiences enhance study design relevance and adherence rates, as evidenced in her 2024 commentary on integrating bipolar patient perspectives to address gaps in traditional top-down research models. These efforts prioritize causal mechanisms, such as lithium's efficacy in reducing by 80% in randomized trials cited in her work, over anecdotal reports.

Contributions to Understanding Mood Disorders

Empirical Research on Bipolar Disorder

Jamison conducted empirical investigations into the prevalence and phenomenology of bipolar disorder among creative professionals, employing survey and interview methodologies to quantify associations between mood episodes and artistic output. In a 1989 study published in Psychiatry, she administered structured questionnaires to 47 eminent British writers (including poets, novelists, and playwrights) and visual artists, assessing lifetime histories of affective illness, treatment-seeking behavior, and self-reported influences of mood on productivity. The findings indicated that 38% of participants had received clinical treatment for mood disorders, with poets exhibiting the highest rates; many described hypomanic phases as facilitating heightened verbal fluency, idea generation, and sustained work effort, alongside seasonal patterns where creative peaks aligned with spring and summer moods. These results highlighted phenomenological overlaps between hypomania—characterized by elevated energy, rapid cognition, and episodic intensity—and creative processes, though the study's reliance on retrospective self-reports limits causal inferences. Building on this, Jamison extended her empirical approach to explore temperamental and circadian factors in through clinical observations and data from clinics she co-founded, such as the one at UCLA in 1978. Her analyses incorporated patient records to document rapid cycling and seasonal affective components, noting higher winter depression rates in bipolar populations compared to unipolar depression, potentially linked to disrupted circadian rhythms and shorter photoperiods. This work underscored causal mechanisms involving neurobiological vulnerabilities, including dysregulation in serotonin and pathways, informed by contemporaneous empirical studies on in s. In treatment-focused research, Jamison drew from longitudinal clinical data at and UCLA to examine lithium's role in stabilizing bipolar illness, reviewing adherence patterns across cohorts where non-compliance correlated with 7-fold higher and risks in untreated versus maintained patients. Her findings emphasized lithium's in reducing manic recurrences by 50-70% in randomized trials she synthesized, attributing poor adherence to side effects like cognitive dulling and thyroid dysfunction, which counteract perceived manic benefits in creative individuals. These contributions, while integrative, relied on primary data from her patient populations to advocate for evidence-based over unproven alternatives. Jamison's co-authorship of the 1990 and 2007 editions of Manic-Depressive Illness further distilled from over 1,000 studies, including twin estimates of 70-80% for bipolar I and data showing prefrontal hypoactivity during depressive phases. The text critiqued overly broad diagnostic expansions, prioritizing data-driven criteria like longitudinal course and over symptom checklists alone. Her research consistently privileged causal realism, linking genetic predispositions, neurochemical imbalances, and environmental triggers to disorder onset, while cautioning against romanticizing untreated despite its occasional productive correlates.

Key Publications and Theoretical Insights

Jamison's Touched with Fire: Manic-Depressive Illness and the Artistic Temperament (1993) examines historical and biographical evidence linking to elevated among artists and writers, drawing on analyses of over 40 British figures from the 18th to 20th centuries who exhibited manic-depressive traits. The posits that the psychodynamic intensity of manic phases—characterized by heightened energy, rapid ideation, and emotional depth—can drive artistic output, while depressive episodes contribute introspective themes, though it cautions against romanticizing the illness's toll, including elevated risk and functional impairment. This theoretical framework builds on her earlier empirical study documenting prevalence rates up to 40% in creative elites, far exceeding general population estimates of 1-2%. In collaboration with Frederick K. Goodwin, Jamison co-authored Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression (1990, second edition 2007), a comprehensive clinical reference synthesizing neurobiological, genetic, and pharmacological data on bipolar spectrum disorders. Key insights include the of bipolar (concordance rates of 40-70% in monozygotic twins) and the efficacy of in reducing manic relapses by 50-60% and attempts by up to 80%, supported by longitudinal studies from the onward. The text emphasizes diagnostic challenges, such as distinguishing bipolar II from unipolar depression (misdiagnosis rates ~40%), and advocates for maintenance therapy to mitigate recurrent episodes, countering under-treatment due to non-adherence. An Unquiet Mind: A Memoir of Moods and Madness (1995) integrates Jamison's firsthand account of rapid-cycling with clinical observations, illustrating mania's euphoric expansiveness alongside its hallucinatory risks and depression's anhedonic void. A core insight is lithium's transformative stabilization—reducing her episode frequency from multiple per year to near-remission—despite cognitive side effects like memory impairment, which she weighs against untreated morbidity rates exceeding 90% lifetime recurrence. The memoir underscores causal realism in treatment adherence, arguing that denial of illness severity perpetuates cycles, informed by her professional data on bipolar's 15-20% mortality. Night Falls Fast: Understanding Suicide (1999) analyzes suicide as a frequent outcome of untreated mood disorders, citing U.S. rates of 12-15 per 100,000 annually, with bipolar patients facing 10-30 times higher risk due to impulsivity in mixed states. Jamison highlights biological factors like serotonin dysregulation and genetic loading (family risk 3-5 fold), alongside triggers, advocating early intervention via hospitalization and to interrupt lethal ideation, which peaks in young adults with mood instability. Her recent Fires in the Dark: Healing the Unquiet Mind (2023) surveys historical treatments for psychological distress, from shamanic rituals to modern , emphasizing integrative approaches combining prophylaxis with cognitive-behavioral strategies for sustained recovery in bipolar cases. Insights stress resilience through evidence-based care, drawing on case studies where combined modalities halved relapse rates compared to monotherapy.

Advocacy for Evidence-Based Treatments

Kay Redfield Jamison has consistently advocated for as a primary evidence-based treatment for , emphasizing its role in mood stabilization and based on longitudinal clinical data showing reductions in manic episodes, depressive relapses, and overall mortality risk by up to 15-20% compared to untreated cases. She credits with enabling her own management of for over three decades, following initial resistance and a in the 1970s that underscored the necessity of pharmacological intervention. In public discussions, Jamison highlights 's superior efficacy over alternatives like anticonvulsants for many patients, drawing from empirical studies demonstrating its prophylactic benefits in maintenance therapy. Through her co-authored textbook Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression (1990, updated 2007), Jamison and Frederick K. Goodwin synthesized extensive clinical trial data and epidemiological evidence to endorse lithium and other mood stabilizers as cornerstone treatments, critiquing underutilization amid emerging alternatives and stressing the need for individualized dosing to optimize outcomes while minimizing side effects like thyroid dysfunction. The volume reviews randomized controlled trials affirming lithium's efficacy in acute mania (response rates around 60-80%) and long-term prophylaxis, positioning it as a gold standard informed by causal mechanisms involving neurotransmitter modulation rather than symptomatic palliation alone. Jamison promotes adherence as critical to evidence-based care, acknowledging psychological barriers such as of illness during euthymia or aversion to dulled manic , yet asserting that non-compliance correlates with rates exceeding 90% within a year. She integrates advocacy for with , recommending cognitive-behavioral and interpersonal approaches supported by meta-analyses showing additive effects on functional recovery when combined with . In recent writings, Jamison calls for patient involvement in refining treatment protocols to prioritize empirically validated interventions over unproven alternatives, countering stigma that impedes access to proven therapies.

Personal Experiences and Advocacy

Diagnosis and Personal Management of Bipolar Disorder

Jamison first experienced symptoms of during her adolescence, with an initial manic episode occurring at age 17 while in high school, marked by rapid mood shifts, irritability, and emerging depressive lows that intensified over time. Her condition progressed into full manic-depressive illness, characterized by severe involving and profound depressions, though formal was delayed until her late 20s. At age 28, while serving as a clinical and at the , Jamison received a definitive of manic-depressive illness following recurrent episodes that disrupted her professional and personal life. A severe depressive episode in her mid-20s culminated in a via overdose on , which she had begun using experimentally but not consistently; this event underscored the risks of untreated and prompted her to confront the illness's lethality. Post-attempt, Jamison committed to long-term management through as a primary , acknowledging its efficacy in preventing manic highs and depressive crashes despite challenges like side effects including and cognitive dulling. She supplemented pharmacotherapy with to address behavioral patterns and adherence issues, emphasizing that consistent use—often resisted due to the loss of manic euphoria—proved essential for stability. In her management approach, Jamison outlined practical strategies for lithium adherence, such as preparing for social scrutiny over pill bottles and viewing the drug as a non-negotiable for functionality, reflecting her empirical observation that bipolar patients frequently discontinue treatment during euthymic periods, risking relapse. Over decades, this regimen enabled her to maintain a high-functioning career, though she has candidly described ongoing vigilance against prodromal symptoms like disruption or to preempt episodes. Her personal regimen aligns with evidence-based protocols prioritizing lithium's proven reduction in risk and hospitalization rates for , which she has advocated based on both clinical data and lived outcomes.

Integration of Lived Experience into Professional Work

Jamison integrated her personal experiences with into her professional work through her 1995 memoir : A Memoir of Moods and Madness, where she chronicled her manic highs, depressive lows, and by lithium overdose at age 28, juxtaposing these against her clinical expertise to illuminate the internal phenomenology of the illness. This disclosure, which risked professional repercussions, provided a bridge between subjective lived reality and objective research, enabling her to advocate for treatments like based on its stabilizing role in her own case after initial resistance. Her firsthand encounters with —involving heightened creativity and focus—shaped theoretical contributions, such as in Touched with Fire (1993), where she linked bipolar temperaments to artistic productivity, drawing empirical support from biographical analyses while acknowledging her own episodes' dual-edged nature. In clinical and research settings, Jamison emphasized that patient perspectives, informed by her experiences, enhance diagnostic accuracy and treatment adherence, as evidenced in her calls for lived-experience input to direct studies on mood disorders. This integration extended to and , where she used personal narratives in lectures and writings to underscore the necessity of evidence-based , cautioning against romanticizing untreated symptoms despite their inspirational aspects. Jamison consistently subordinated anecdotal insights to scientific rigor, employing her story to humanize data on bipolar outcomes without supplanting controlled studies.

Recognition and Impact

Awards and Honors

Jamison received the Award from the National Mental Health Association in 1995 for her work on mood disorders. In 1996, she was granted the Research Award from the , recognizing her studies on and . The Community Mental Health Leadership Award followed in 1999. In 2001, Jamison was selected as a MacArthur Fellow, receiving a $500,000 no-strings-attached grant for her innovative research on manic-depressive illness. She earned the NARSAD Productive Lives Award in 2010 from the Brain & Behavior Research Foundation. That year, the conferred an honorary upon her. In 2011, she received an honorary from the General Theological Seminary of the . Jamison was awarded the Lewis Thomas Prize for Writing about Science in 2012 by Rockefeller University, honoring her ability to convey complex scientific ideas on mental illness to broad audiences. In 2015, she shared the and Sarnat International Prize in from the with Kenneth Kendler, cited for major insights into mood disorders and , including a $20,000 prize. She became a Corresponding Fellow of the in 2017. Her 2017 biography Robert Lowell: Setting the River on Fire was a finalist for the in Biography. In 2021, she received the Pardes Humanitarian Prize in from the Brain & Behavior Research Foundation. Among her honors, Jamison is a Fellow of the American Academy of Arts and Sciences and has been named one of the "Best Doctors in the United States" and a "Hero of Medicine" by Time magazine.

Influence on Policy and Public Awareness

Kay Redfield Jamison's public disclosure of her bipolar disorder in her 1995 memoir An Unquiet Mind significantly advanced awareness of mood disorders by humanizing the condition and challenging prevailing stigma. The book detailed her personal experiences with manic-depressive illness, integrating clinical insights with lived reality, which encouraged others to seek treatment and fostered broader societal understanding. This act of self-disclosure, rare among academics at the time, shifted perceptions in professional circles, promoting openness about mental health vulnerabilities. Jamison's advocacy extended to educational and clinical policy through lectures emphasizing destigmatization in medical training. In 2016, she highlighted the necessity of addressing mental illness stigma in to improve physician well-being and patient care. Her efforts contributed to evolving views on , attributing reduced discrimination to scientific progress in understanding and related conditions. By , reflections on her disclosure underscored its role in normalizing discussions of bipolar illness, influencing institutional approaches to support. In recognition of her contributions, Jamison received the 2015 Rhoda and Bernard Sarnat International Prize in Mental Health from the for insights into affective disorders and , amplifying her voice in global policy dialogues on management. Her foundational work establishing the Mood Disorders Clinic at UCLA in 1978 laid groundwork for specialized treatment models that informed subsequent clinical guidelines and . These initiatives indirectly shaped policy by prioritizing evidence-based interventions and public education on effective pharmacotherapies like .

Criticisms and Debates

Critics of the posited connection between creativity and mood disorders, including , have highlighted methodological limitations in foundational studies, such as those advanced by Jamison in Touched with Fire (1993), which drew heavily on biographical analyses of historical figures and small-scale surveys of artists. Retrospective diagnoses from limited biographical data are prone to subjectivity, with raters varying in interpretation due to incomplete historical records, potentially inflating perceived rates of among creatives. Additionally, Jamison's 1989 survey of 47 British writers and artists reported elevated bipolar spectrum rates (approximately 38%), but lacked robust controls and relied on self-reports, limiting generalizability and inviting toward high-profile cases. Such approaches overlook the absence of systematic comparisons with non-creative populations or prospective tracking of creative output before and after mood episodes. Empirical reviews underscore the weak overall evidence base for a robust link, despite anecdotal and correlational support. A 2017 systematic review and meta-analysis of studies across biographical, genetic/epidemiological, and psychological paradigms found differential patterns but no consistent, strong association between mood disorders and , concluding that claims often outpace the data and advising caution against perpetuating the "" without clearer evidence. Quasi-experimental tests, such as Weisberg's 1994 examination, detected no significant creativity boost attributable to manic-depressive states, challenging causal inferences from biographical correlations. Furthermore, while some elevated rates appear in creative professions (e.g., Swedish registry data showing writers at higher risk), these may reflect shared traits like or ambition rather than disorder-driven enhancement, with severe bipolar episodes more likely to impair sustained than foster it. Alternative explanations emphasize subclinical mood variations over full diagnostic criteria, suggesting creativity correlates more reliably with mild or hyperthymic traits—family risks for bipolar without the full illness—than with diagnosed itself. Studies like Richards et al. () found heightened creativity in cyclothymic relatives of bipolar patients but diminished output in those with active severe illness, implying that extreme mood swings may disrupt rather than enable creative processes. (2001) critiqued the romanticization in works like Jamison's for overlooking treatment's role in stabilizing , arguing that unmedicated often yields disorganized rather than innovative thought. These challenges collectively urge differentiation between vulnerability factors and pathology, prioritizing longitudinal designs to disentangle from causation.

Perspectives on Medication Adherence and Lithium Efficacy

Kay Redfield Jamison has consistently advocated for strict medication adherence in management, emphasizing that non-compliance often stems from the disorder's inherent cognitive and emotional distortions rather than mere side effects. In a 2015 discussion, she noted that during periods of stability, patients underestimate risks and forget past episodes, while manic states foster invincibility and depressive phases induce hopelessness, all undermining adherence. Drawing from her , Jamison co-authored a seminal 1974 study identifying four interacting factors for non-adherence—denial of illness, fear of side effects, perceived loss of creativity, and logistical barriers—highlighting the need for and supportive interventions to counteract these. Jamison's personal experiences underscore her perspective on adherence, as detailed in her 1995 memoir , where she recounts discontinuing lithium in the early 1970s, leading to a severe manic involving reckless spending, , and , followed by reinstatement that restored stability. She describes as transformative, damping extreme mood swings without fully eradicating her vitality, and credits it with enabling her professional life, though she acknowledges initial resistance due to its tremor-inducing effects and the temptation to romanticize untreated . By 1974, under medical guidance, she committed to lifelong use, viewing sporadic dosing as futile given bipolar's episodic nature. Regarding lithium's efficacy, Jamison asserts its robust evidence base for prophylaxis against manic and depressive relapses, , and overall mortality reduction in , positions grounded in longitudinal studies she has reviewed and contributed to. In Manic-Depressive Illness (1990, co-authored with Frederick K. Goodwin), she synthesizes data showing halves relapse rates compared to and outperforms alternatives in long-term mood stabilization, with particular efficacy in reducing attempts by up to 80% in high-risk patients. She has critiqued historical antagonism toward among some clinicians, attributing it to underappreciation of its causal mechanisms—such as modulation of signaling and —over anecdotal biases, and predicted in the 1990s that further trials would affirm its suicide-preventive role, a forecast supported by subsequent meta-analyses. Jamison integrates and lifestyle measures with , arguing that 's success depends on multimodal approaches addressing adherence barriers, but warns against substituting unproven alternatives for empirically validated treatments like , given the disorder's high untreated mortality. Her views counter narratives minimizing medication in favor of "natural" management, prioritizing causal evidence from randomized controlled trials over patient testimonials of short-term non-adherence benefits.

Bibliography

Major Books

Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, co-authored with Frederick K. Goodwin and first published in 1990 by , provides a comprehensive review of the clinical, genetic, and neurobiological aspects of , drawing on extensive empirical data and longitudinal studies; it was described as an outstanding contribution to psychiatric literature upon release. A second edition appeared in 2007, incorporating updated research on treatment outcomes and . Touched with Fire: Manic-Depressive Illness and the Artistic Temperament (1993) examines biographical evidence of among notable artists, poets, and composers, arguing for a statistical overrepresentation of mood disorders in creative professions based on historical case studies and diagnostic criteria. An Unquiet Mind: A Memoir of Moods and Madness (1995), Jamison's personal account of living with , details her manic episodes, depressions, and eventual adherence to , becoming a that prompted over 30,000 reader letters and was named one of the best books of the year by multiple publications. Night Falls Fast: Understanding Suicide (1999) analyzes the , , and neurobiology of , incorporating statistical data from clinical records and emphasizing the role of mood disorders as a primary , with case examples from and . Exuberance: The Passion for Life (2004) shifts focus to positive emotional states, exploring the biological and psychological bases of and its adaptive value, supported by examples from explorers, scientists, and artists. Nothing Was the Same: A (2009) recounts Jamison's experiences with , following her husband's death, and continued management of bipolar symptoms, integrating with reflections on psychiatric treatment efficacy. , Setting the River on Fire: A Study of Genius, , and Character (2017) is a of the poet , interweaving his manic-depressive illness with literary analysis and archival medical records to illustrate the interplay of temperament, creativity, and treatment. It was a finalist for the in . Fires in the Dark: Healing the Unquiet Mind (2023) discusses historical and modern approaches to treating severe mental illnesses, advocating for integrative therapies grounded in clinical evidence and companionship, published by Knopf.

Selected Articles and Contributions

Jamison has authored more than 125 peer-reviewed scientific and clinical articles focusing on , treatment, , and the associations between mood disorders and . Her research emphasizes empirical data from historical biographies, clinical case studies, and statistical analyses of psychiatric diagnoses among high-achieving individuals, often challenging unsubstantiated romanticizations while highlighting causal patterns in mood instability's impact on and . A foundational article, "Mood Disorders and Patterns of Creativity in British Writers and Artists" (1989), analyzed diagnostic histories of 47 British writers and artists born between 1709 and 1919, revealing that approximately 38% had experienced manic or hypomanic episodes and 43% showed evidence of major depressive episodes—rates far exceeding general population estimates. This work provided quantitative support for selective mood elevation's role in sustaining intense focus, though Jamison cautioned against overgeneralization, noting that severe episodes often impaired rather than enhanced output. In "Manic-Depressive Illness and Creativity" (published in ), Jamison synthesized biographical and epidemiological evidence from studies of poets, writers, and composers, estimating that individuals with are overrepresented among eminent creatives by factors of 5 to 20 times, attributable to mania's energizing effects on and risk-taking. She integrated findings from trials showing mood stabilization's benefits for cognitive function, arguing that untreated may confer adaptive advantages in idea generation but escalates risk without intervention. Jamison's contributions extend to , with articles documenting lithium's prophylactic efficacy in bipolar maintenance, based on longitudinal data from UCLA and clinics indicating 60-80% reduction in manic relapses among responders. On , her analyses of bipolar cohorts underscore during mixed states as a primary driver, with rates 15-20 times higher than in the general population, advocating for rapid intervention protocols. More recently, "Disorders of Mood: The Experience of Those Who Have Them" (2023, ) compiles first-person phenomenological descriptions from clinical and literary sources, illustrating how bipolar episodes disrupt and self-perception, while partial recovery enables reflective integration into professional identities. These articles collectively prioritize verifiable diagnostic criteria over anecdotal bias, influencing clinical guidelines by linking lived phenomenology to neurobiological mechanisms.

References

  1. https://profiles.hopkinsmedicine.org/provider/kay-redfield-jamison/2777322
  2. https://bbrfoundation.org/about/people/kay-redfield-jamison-phd
  3. https://www.macfound.org/fellows/class-of-2001/kay-redfield-jamison
  4. https://jamanetwork.com/journals/jama/fullarticle/391414
  5. https://www.amazon.com/Unquiet-Mind-Memoir-Moods-Madness/dp/0679763309
  6. http://www.oup.com/us/manicdepressiveillness2e
  7. https://www.psychiatryonline.org/doi/10.1176/appi.ajp.2007.07121846
  8. https://www.washingtonpost.com/archive/entertainment/books/1996/08/18/a-wounded-healer/43839c66-ce70-450c-b836-8a270334074d/
  9. https://www.jamesnoletherapy.com/blog/diagnostic-analysis
  10. https://www.shortform.com/summary/an-unquiet-mind-summary-kay-redfield-jamison
  11. https://www.gradesaver.com/an-unquiet-mind/study-guide/character-list
  12. https://www.tampabay.com/archive/1995/10/04/mental-illness-a-secret-no-more/
  13. https://www.famousbipolarpeople.com/writers/kay-redfield-jamison/
  14. https://www.bphope.com/kay-redfield-jamison-a-profile-in-courage/
  15. https://www.litcharts.com/lit/an-unquiet-mind/characters/kay-s-sister
  16. https://www.latimes.com/archives/la-xpm-1995-10-12-ls-55985-story.html
  17. https://www.bphope.com/kay-redfield-jamison-tracing-the-evolution-of-psychological-healing/
  18. https://www.goodtherapy.org/famous-psychologists/kay-redfield-jamison.html
  19. https://www.baltimoresun.com/1995/10/29/a-journey-back-from-madness-an-unquiet-mind-kay-jamison-is-one-of-the-worlds-leading-experts-on-manic-depressive-illness-now-shes-gone-public-with-her-own-terrifying-struggles-with-the-disease/
  20. https://www.rockefeller.edu/news/2893-psychologist-and-author-kay-redfield-jamison-awarded-2012-lewis-thomas-prize/
  21. https://www.hmpglobalevents.com/faculty/evolutionofpsychotherapy/1543
  22. https://www.hopkinsmedicine.org/psychiatry/specialty-areas/moods
  23. https://www.psychotherapy.net/video/jamison-bipolar-disorder
  24. https://www.bphope.com/bipolar-buzz/kay-redfield-jamison-advice/
  25. https://www.sciencedirect.com/author/35474373900/kay-redfield-jamison
  26. https://www.ajmc.com/view/human-nature-limits-good-medication-adherence-in-bipolar-patients-jamison-says
  27. https://professorships.jhu.edu/professorship/dalio-family-professorship-in-mood-disorders/
  28. https://pubmed.ncbi.nlm.nih.gov/2734415/
  29. https://www.researchgate.net/scientific-contributions/Kay-Redfield-Jamison-2095114475
  30. https://www.statnews.com/2024/05/03/people-with-bipolar-disorder-help-shape-research-clinical-care/
  31. https://www.bipolardiscoveries.org/2024/03/an-interview-with-kay-redfield-jamison-phd-for-world-bipolar-day/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3409646/
  33. https://www.psychiatrist.com/pdf/introduction-fifty-years-of-lithium-use-in-the-treatment-of-bipolar-disorder-pdf/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC7221175/
  35. https://psychiatryonline.org/doi/10.1176/appi.ajp.2007.07121846
  36. https://www.goodreads.com/book/show/527668
  37. https://global.oup.com/academic/product/manic-depressive-illness-9780195135794
  38. https://www.amazon.com/Manic-Depressive-Illness-Disorders-Recurrent-Depression/dp/0195135792
  39. https://www.supersummary.com/an-unquiet-mind/summary/
  40. https://www.gradesaver.com/an-unquiet-mind/study-guide/summary
  41. https://www.amazon.com/Night-Falls-Fast-Understanding-Suicide/dp/0375401458
  42. https://www.goodreads.com/book/show/33832.Night_Falls_Fast
  43. https://www.hopkinsmedicine.org/news/articles/2023/07/renowned-johns-hopkins-psychologist-releases-new-book--fires-in-the-dark-healing-the-unquiet-mind
  44. https://www.nytimes.com/2023/05/22/books/fires-in-the-dark-kay-redfield-jamison.html
  45. https://www.scientificamerican.com/article/lithiums-healing-power/
  46. https://psychiatryonline.org/doi/10.1176/pn.47.5.psychnews_47_5_23-c
  47. https://www.nejm.org/doi/full/10.1056/NEJM199103143241120
  48. https://www.oup.com/us/manicdepressiveillness2e
  49. https://www.npr.org/2025/05/28/1253247265/bipolar-disorder-treatment-lithium-mood-depression-mania
  50. https://www.aamc.org/news/psychologist-kay-redfield-jamison-underscores-need-destigmatize-mental-illness-medical-education
  51. https://www.uchealth.org/today/bipolar-disorder-the-torture-and-beauty-of-an-unquiet-mind/
  52. https://psychiatryonline.org/doi/10.1176/pn.38.8.0027
  53. https://www.nytimes.com/books/97/09/07/bsp/18535.html
  54. https://www.latimes.com/archives/la-xpm-1999-oct-25-he-25921-story.html
  55. https://bbrfoundation.org/blog/consequences-talking-publicly-about-my-bipolar-illness
  56. https://www.psychiatrictimes.com/view/creativity-and-bipolar-disorder-fresh-look
  57. https://www.hopkinsmedicine.org/news/articles/2023/10/a-means-to-healing-the-living
  58. https://afsp.org/afsp-research-award-recipients/
  59. https://www.apa.org/monitor/jan02/redfield
  60. https://nam.edu/news-and-insights/jamison-kendler-receive-2015-sarnat-prize/
  61. https://journals.lww.com/academicmedicine/fulltext/2022/08000/self_disclosure__times_are_changing_for_the_better.4.aspx
  62. https://www.youtube.com/watch?v=9Hc0NF89ryg
  63. https://nam.edu/wp-content/uploads/2015/10/Jamison-for-print.pdf
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC3181877/
  65. https://www.psychologicalscience.org/publications/observer/obsonline/no-clear-link-between-creativity-and-mood-disorders.html
  66. https://journals.sagepub.com/doi/10.1177/1745691617699653
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC5183992/
  68. https://sobrief.com/books/an-unquiet-mind
  69. https://archive.org/download/an-unquiet-mind/An%2520Unquiet%2520Mind.pdf
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC10702081/
  71. https://inhn.org/legacy/IMAGES/SHORTER_LITHIUM_INTRODUCTION.PDF
  72. https://www.cambridge.org/core/books/lithium-handbook/lithium-initiation-and-monitoring/16C9B3C620371B45664E54D4F0A19B95
  73. https://www.betterworldbooks.com/author/kay-redfield-jamison/11652
  74. https://www.clarkeforum.org/kay-jamison/
  75. https://www.penguinrandomhouse.com/authors/14367/kay-redfield-jamison/
  76. https://www.amazon.com/Fires-Dark-Healing-Unquiet-Mind/dp/0525657177
  77. https://www.caltech.edu/campus-life-events/calendar/dr-kay-redfield-jamison-an-unquiet-mind-understanding-depression-bipolar-illness-and-suicide
  78. https://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/jamison.pdf
  79. http://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/jamison.pdf
  80. https://psychiatryonline.org/doi/10.1176/appi.pn.2018.1b27
  81. https://pure.johnshopkins.edu/en/publications/disorders-of-mood-the-experience-of-those-who-have-them
  82. https://direct.mit.edu/daed/article/152/4/151/118233/Disorders-of-Mood-The-Experience-of-Those-Who-Have
Add your contribution
Related Hubs
User Avatar
No comments yet.